| Quarter | Score |
|---|---|
| 2022-Q1 | 49.4 |
| 2022-Q3 | 70.6 |
| 2022-Q4 | 50.7 |
| 2023-Q1 | 50.0 |
| 2023-Q2 | 64.4 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 92.1 |
| 2024-Q2 | 52.0 |
| 2024-Q3 | 77.1 |
| 2024-Q4 | 75.4 |
| 2025-Q1 | 75.7 |
| 2025-Q2 | 75.6 |
| 2025-Q3 | 75.7 |
| 2025-Q4 | 75.7 |
| 2026-Q1 | 62.3 |
| 2026-Q2 | 86.9 |
High consensus with active accumulation at an attractive valuation
Trading +18.1% above funds' estimated purchase price
2 of 18 tracked funds hold MA. Avg conviction: 2.8%. Net adding. First tracked at $503.70 (current +18.1% vs tracked).
Pershing Square has 5.6% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Pershing Square | 5.6% | New Buy |
| Citadel Advisors | 0.1% | Add |